AGEAS/S (OTCMKTS:AGESY) versus PETROFAC LTD/ADR (OTCMKTS:POFCY) Head to Head Analysis

Share on StockTwits

AGEAS/S (OTCMKTS:AGESY) and PETROFAC LTD/ADR (OTCMKTS:POFCY) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

Insider & Institutional Ownership

0.3% of AGEAS/S shares are owned by institutional investors. Comparatively, 0.0% of PETROFAC LTD/ADR shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

AGEAS/S has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, PETROFAC LTD/ADR has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for AGEAS/S and PETROFAC LTD/ADR, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AGEAS/S 0 0 0 0 N/A
PETROFAC LTD/ADR 0 2 1 0 2.33

Dividends

AGEAS/S pays an annual dividend of $1.71 per share and has a dividend yield of 3.0%. PETROFAC LTD/ADR pays an annual dividend of $0.11 per share and has a dividend yield of 4.3%. AGEAS/S pays out 35.3% of its earnings in the form of a dividend. PETROFAC LTD/ADR pays out 21.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. PETROFAC LTD/ADR is clearly the better dividend stock, given its higher yield and lower payout ratio.

Earnings and Valuation

This table compares AGEAS/S and PETROFAC LTD/ADR’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AGEAS/S $13.97 billion 0.81 $955.55 million $4.85 11.79
PETROFAC LTD/ADR $5.83 billion 0.31 $64.00 million $0.52 4.94

AGEAS/S has higher revenue and earnings than PETROFAC LTD/ADR. PETROFAC LTD/ADR is trading at a lower price-to-earnings ratio than AGEAS/S, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AGEAS/S and PETROFAC LTD/ADR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AGEAS/S 7.02% 8.11% 0.92%
PETROFAC LTD/ADR N/A N/A N/A

Summary

AGEAS/S beats PETROFAC LTD/ADR on 9 of the 13 factors compared between the two stocks.

About AGEAS/S

ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. It operates through Belgium, United Kingdom, Continental Europe, Asia, and Reinsurance segments. The company primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire, and other insurance products, as well as other damages to property covering the risk of property losses or claims liabilities. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is based in Brussels, Belgium.

About PETROFAC LTD/ADR

Petrofac Ltd. engages in the provision of services to the oil and gas production and processing industry. It offers engineering and construction; operations and maintenance; and training and competence. The company was founded in 1981 and is headquartered in St. Helier, the United Kingdom.

Receive News & Ratings for AGEAS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGEAS/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Saia  Stock Rating Lowered by BidaskClub
Saia Stock Rating Lowered by BidaskClub
Omnicell  Lifted to Buy at BidaskClub
Omnicell Lifted to Buy at BidaskClub
Medpace  Lifted to “Hold” at BidaskClub
Medpace Lifted to “Hold” at BidaskClub
Helen of Troy  Stock Rating Lowered by BidaskClub
Helen of Troy Stock Rating Lowered by BidaskClub
Corbus Pharmaceuticals  Lifted to Sell at BidaskClub
Corbus Pharmaceuticals Lifted to Sell at BidaskClub
American Woodmark  Stock Rating Upgraded by BidaskClub
American Woodmark Stock Rating Upgraded by BidaskClub


 
© 2006-2019 Zolmax.